1. 智能化融合:发展数据挖掘、集成、分析、可视化及人工智能工具,实现数据与文献、模型、计算等资源的有机融合,促进领域数智驱动科研新范式变革.
2. 标准化体系建设:以统一的数据标准管理体系为基础,系统整合全链条多源异构数据,聚焦高价值业务需求,精准构建结构合理、标注规范、语义清晰的数据资源.
3. 开放共享生态:开展数据提供方、使用方和服务方生态体系建设,实现多元主体间数据共享、共用、共治。.
4. 多模态数据处理:构建“全模态数据治理平台+高质量数据服务”一体化解决方案,提升非结构化数据处理能力.

Ceritinib, also known as LDK378, is a selective inhibitor of ALK1, a target found in metastatic non-small cell lung cancer (NSCLC). In Phase I trials, LDK378 showed a marked clinical response in 78 pa...
Marsilje, Thomas H.; Pei, Wei; Chen, Bei; Lu, Wenshuo; Uno, Tetsuo; Jin, Yunho; Jiang, Tao; Kim, Sungjoon; Li, Nanxin; Warmuth, Markus; Sarkisova, Yelena; Sun, Frank; Steffy, Auzon; Pferdekamper, AnneMarie C.; Li, Allen G.; Joseph, Sean B.; Kim, Young; Liu, Bo; Tuntland, Tove; Cui, Xiaoming; Gray, Nathanael S.; Steensma, Ruo; Wan, Yongqin; Jiang, Jiqing; Chopiuk, Greg; Li, Jie; Gordon, W. Perry; Richmond, Wendy; Johnson, Kevin; Chang, Jonathan; Groessl, Todd; He, You-Qun; Phimister, Andrew; Aycinena, Alex; Lee, Christian C.; Bursulaya, Badry; Karanewsky, Donald S.; Seidel, H. Martin; Harris, Jennifer L.; Michellys, Pierre-Yves. Synthesis, Structure-Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials. Journal of Medicinal Chemistry. Volume 56. Issue 14. Pages 5675-5690. Journal; Online Computer File. (2013).
Telotristat ethyl, also known as LX 1032 or LX 1606, is an oral serotonin synthesis inhibitor or peripheral tryptophan hydroxylase (TPH) inhibitor . Telotristat etiprate has activity in controlling di...
Reference: Sands, Arthur Thomas. Preparation of multicyclic amino acid derivations as potent and selective THP1 inhibitors for treating metastatic bone disease. WO 2011100285. (Lexicon Pharmaceuticals, Inc., USA)
Sarecycline, also known as WC-3035 and P005672, is a novel, tetracycline-derived, narrow-spectrum antibiotic being developed for use as an oral once daily antibiotic treatment for patients suffering f...
Reference: Assefa, Haregewin; Bhatia, Beena; Draper, Michael; Honeyman, Laura; Molnar, Dennis P.; Kim, Oak K. Preparation of substituted tetracycline compounds for treatment of inflammatory skin disorders. Assignee Paratek Pharmaceuticals, Inc., USA. CA 2892739. (2008).
Niraparib, also known as MK4827, is an orally active, potent and selective poly(ADP-Ribose) polymerase (PARP) inhibitor that radiosensitizes human lung and breast cancer cells. Niraparib inhibits PARP...
Reference: Jones, Philip; Ontoria Ontoria, Jesus Maria; Scarpelli, Rita; Schultz-Fademrecht, Carsten. Preparation of piperidinylphenylindazolylcarboxamide for use as poly(ADP-ribose)polymerase inhibitors. WO 2008084261. (Assignee Istituto Di Ricerche Di Biologia Molecolare P. Angeletti SpA, Italy)
Finerenone (BAY 94-8862) is a novel, selective non-steroidal mineralocorticoid receptor (MR) antagonist. In preclinical studies, it bound the MR with high affinity (Ki ~18 nM) and demonstrated greater...
Discovery of BAY 94-8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal DiseasesBy: Baerfacker, Lars; et alChemMedChem (2012), 7(8), 1385-1403
Cabotegravir is a potent HIV-1 integrase strand transfer inhibitor (INSTI) that demonstrates strong in vitro activity, blocking viral DNA integration into host genomes at nanomolar concentrations with...
7-Step Flow Synthesis of the HIV Integrase Inhibitor DolutegravirBy: Ziegler, Robert E.; et alAngewandte Chemie, International Edition (2018), 57(24), 7181-7185
Dolutegravir, also known as GSK1349572, is a potent inhibitor of HIV integrase with an IC50 value of 2.7 nM for HIV-1 integrase-catalyzed strand transfer in vitro.1 It inhibits HIV-1 viral replication...
Aoyama, Yasunori; Hakogi, Toshikazu; Fukui, Yuki; Yamada, Daisuke; Ooyama, Takao; Nishino, Yutaka; Shinomoto, Shoji; Nagai, Masahiko; Miyake, Naoki; Taoda, Yoshiyuki; Yoshida, Hiroshi; Yasukata, Tatsuro. Practical and Scalable Synthetic Method for Preparation of Dolutegravir Sodium: Improvement of a Synthetic Route for Large-Scale Synthesis. Organic Process Research & Development. Volume 23. Issue 4. Pages 558-564. Journal; Online Computer File. (2019).
Momelotinib is a potent, selective inhibitor of Janus kinases JAK1 and JAK2, as well as activin A receptor type I (ACVR1/ALK2). In vitro, it inhibits JAK1, JAK2, and ACVR1 with IC₅₀ values of 11 nM, 1...
Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitorBy: Desai, Jigar; et alBioorganic & Medicinal Chemistry Letters (2022), 66, 128728
Lefamulin, also known as BC-3781, is a semi-synthetic compound that inhibits the synthesis of bacterial protein, which is required for bacteria to grow. Lefamulin acts by binding to the peptidyl trans...
Reference: Heilmayer, Werner; Mang, Rosemarie; Badegruber, Rudolf; Stickmann, Dirk; Novak, Rodger; Ferencic, Mathias; Bulusu, Atchyuta Rama Chandra Murty. Synthesis of pleuromutilin derivatives for the treatment of diseases mediated by microbes. MX 2010009451. (2012).
Rufinamide is a board spectrum anticonvulsant. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. Rufinamide was approved...
Zhang, Ping; Russell, M. Grace; Jamison, Timothy F. Continuous Flow Total Synthesis of Rufinamide. Organic Process Research & Development. Volume 18. Issue 11. Pages 1567-1570. 2014.
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
